Skip to Main Content

Advertisement

Skip Nav Destination

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Clin Cancer Res (1995) 1 (7): 691–697.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal